Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis
- 1 November 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 30 (6) , 531-538
Abstract
Purpose of review Intestinal fibrosis is a serious, yet common, outcome in patients with inflammatory bowel disease (IBD). Despite advances in developing novel treatment modalities to control chronic gut inflammation characteristic of IBD, no effective antifibrotic therapies exist to date. As such, a deeper understanding of the molecular mechanisms underlying intestinal fibrosis and the availability of relevant animal models are critical to move this area of investigation forward. Recent findings Emerging concepts in the pathogenesis of intestinal fibrosis include the central role of interleukin (IL)-17 and Th17 immune responses, although their precise contribution to chronic inflammation and IBD remains controversial. Other novel mediators of intestinal fibrosis, such as tumor necrosis factor-like ligand 1A and components of the renin-angiotensin system, support the importance of IL-17. Additionally, recent studies utilizing novel mouse models highlight the significance of the gut microbiota and link components of bacterial sensing, including nucleotide-binding oligomerization domain-containing protein 2, to IL-17/Th17 immune responses in the development of inflammation-associated intestinal fibrosis. Summary Recent progress in identifying key mediators, novel animal models, and important mechanistic pathways in the pathogenesis of intestinal fibrosis holds promise for the development of effective antifibrotics in an area of significant, unmet clinical need.Keywords
This publication has 71 references indexed in Scilit:
- Angiotensin II Is a New Component Involved in Splenic T Lymphocyte Responses during Plasmodium berghei ANKA InfectionPLOS ONE, 2013
- Sustained TL1A(TNFSF15)expression on both lymphoid and myeloid cells leads to mild spontaneous intestinal inflammation and fibrosisEuropean Journal of Microbiology and Immunology, 2013
- Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1Cellular Signalling, 2012
- Constitutive TL1A Expression under Colitogenic Conditions Modulates the Severity and Location of Gut Mucosal Inflammation and Induces FibrostenosisThe American Journal of Pathology, 2012
- SAMP1/YitFc mouse strain: A spontaneous model of Crohnʼs disease-like ileitisInflammatory Bowel Diseases, 2011
- Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel diseaseNature Genetics, 2011
- A protective function for interleukin 17A in T cell–mediated intestinal inflammationNature Immunology, 2009
- Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel diseaseNature Genetics, 2008
- TL1A (TNFSF15) Regulates the Development of Chronic Colitis by Modulating Both T-Helper 1 and T-Helper 17 ActivationGastroenterology, 2008
- Angiotensin AT1 receptor antagonists exert anti‐inflammatory effects in spontaneously hypertensive ratsBritish Journal of Pharmacology, 2007